Antiperspirants and Breast Cancer Risk – American Cancer Society

Antiperspirants and Breast Cancer Risk – American Cancer Society

Centers for Disease Control. Parabens (fact sheet). 7/23/2013. Accessed at http://www.cdc.gov/biomonitoring/Parabens_FactSheet.html on 10/14/2014.

Centers for Disease Control. Biomonitoring Summary: Parabens. 12/4/2013. Accessed at www.cdc.gov/biomonitoring/Parabens_BiomonitoringSummary.html on October 14, 2014.

Cosmetic Ingredient Review Expert Panel (CIR). Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products. Int J Toxicol. 2008;27 Suppl 4:1-82.

Darbre PD. Aluminium, antiperspirants and breast cancer. J Inorg Biochem. 2005;99:1912-1919.

Darbre PD. Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. J Appl Toxicol. 2006;26:191-197.

Darbre PD. Underarm antiperspirants/deodorants and breast cancer. Breast Cancer Res. 2009;11 Suppl 3:S5.

Darbre PD, Aljarrah A, Miller WR, et al. Concentrations of parabens in human breast tumours. J Appl Toxicol. 2004;24:5-13.

Darbre PD, Harvey PW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol. 2008;28:561-578.

Flarend R, Bin T, Elmore D, Hem SL. A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26. Food Chem Toxicol. 2001 Feb;39(2):163-168.

Hardefeldt PJ, Edirimanne S, Eslick GD. Deodorant use and breast cancer risk. Epidemiology. 2013 Jan;24(1):172.

McGrath KG. An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. Eur J Cancer Prev. 2003;12:479-485.

McGrath KG. Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century. Med Hypotheses. 2009;72:665-674.

Mirick DK, Davis S, Thomas, DB: Antiperspirant Use and the Risk of Breast Cancer. J Natl Cancer Inst. 2002;94:1578-1580.

Namer M, Luporsi E, Gligorov J, Lokiec F, Spielmann M. The use of deodorants/antiperspirants does not constitute a risk factor for breast cancer [article in French]. Bull Cancer. 2008;95:871-880.

National Cancer Institute Fact Sheets. Antiperspirants/Deodorants and Breast Cancer. 1/4/2008. Accessed at http://www.cancer.gov/cancertopics/factsheet/Risk/AP-Deo on August 16, 2013..

Rados C. Antiperspirant Awareness: It’s Mostly No Sweat. FDA Consumer Magazine. July-August 2005. Accessed at www.medicinenet.com/script/main/art.asp?articlekey=53207 on September 5, 2013.

Robb-Nicholson C. By the way, doctor. I recently received an e-mail warning about a risk for breast cancer associated with using antiperspirants. Are you familiar with this theory? Is it valid? Harvard Womens Health Watch. 2001;8:7.

Rodrigues-Peres RM, Cadore S, Febraio S, Heinrich JK, Serra KP, Derchain SF, Vassallo J, Sarian LO. Aluminum concentrations in central and peripheral areas of malignant breast lesions do not differ from those in normal breast tissues. BMC Cancer. 2013 Mar 8;13:104.

Surendran A. Studies linking breast cancer to deodorants smell rotten, experts say. Nature Medicine. 2004;10:216.

US Food and Drug Administration. Parabens. 10/31/2007. Accessed at http://www.fda.gov/cosmetics/productsingredients/ingredients/ucm128042.htm on October 14, 2014.

US Food and Drug Administration. Federal Register, June 9, 2003. Antiperspirant Drug Products For Over-the-Counter Human Use; Final Monograph. Accessed at http://www.fda.gov/ohrms/dockets/98fr/03-14140.htm on September 5, 2013.

Centers for Disease Control. Parabens (fact sheet). 7/23/2013. Accessed at http://www.cdc.gov/biomonitoring/Parabens_FactSheet.html on 10/14/2014.

Centers for Disease Control. Biomonitoring Summary: Parabens. 12/4/2013. Accessed at www.cdc.gov/biomonitoring/Parabens_BiomonitoringSummary.html on October 14, 2014.

Cosmetic Ingredient Review Expert Panel (CIR). Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products. Int J Toxicol. 2008;27 Suppl 4:1-82.

Darbre PD. Aluminium, antiperspirants and breast cancer. J Inorg Biochem. 2005;99:1912-1919.

Darbre PD. Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. J Appl Toxicol. 2006;26:191-197.

Darbre PD. Underarm antiperspirants/deodorants and breast cancer. Breast Cancer Res. 2009;11 Suppl 3:S5.

Darbre PD, Aljarrah A, Miller WR, et al. Concentrations of parabens in human breast tumours. J Appl Toxicol. 2004;24:5-13.

Darbre PD, Harvey PW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol. 2008;28:561-578.

Flarend R, Bin T, Elmore D, Hem SL. A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26. Food Chem Toxicol. 2001 Feb;39(2):163-168.

Hardefeldt PJ, Edirimanne S, Eslick GD. Deodorant use and breast cancer risk. Epidemiology. 2013 Jan;24(1):172.

McGrath KG. An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. Eur J Cancer Prev. 2003;12:479-485.

McGrath KG. Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century. Med Hypotheses. 2009;72:665-674.

Mirick DK, Davis S, Thomas, DB: Antiperspirant Use and the Risk of Breast Cancer. J Natl Cancer Inst. 2002;94:1578-1580.

Namer M, Luporsi E, Gligorov J, Lokiec F, Spielmann M. The use of deodorants/antiperspirants does not constitute a risk factor for breast cancer [article in French]. Bull Cancer. 2008;95:871-880.

National Cancer Institute Fact Sheets. Antiperspirants/Deodorants and Breast Cancer. 1/4/2008. Accessed at http://www.cancer.gov/cancertopics/factsheet/Risk/AP-Deo on August 16, 2013..

Rados C. Antiperspirant Awareness: It’s Mostly No Sweat. FDA Consumer Magazine. July-August 2005. Accessed at www.medicinenet.com/script/main/art.asp?articlekey=53207 on September 5, 2013.

Robb-Nicholson C. By the way, doctor. I recently received an e-mail warning about a risk for breast cancer associated with using antiperspirants. Are you familiar with this theory? Is it valid? Harvard Womens Health Watch. 2001;8:7.

Rodrigues-Peres RM, Cadore S, Febraio S, Heinrich JK, Serra KP, Derchain SF, Vassallo J, Sarian LO. Aluminum concentrations in central and peripheral areas of malignant breast lesions do not differ from those in normal breast tissues. BMC Cancer. 2013 Mar 8;13:104.

Surendran A. Studies linking breast cancer to deodorants smell rotten, experts say. Nature Medicine. 2004;10:216.

US Food and Drug Administration. Parabens. 10/31/2007. Accessed at http://www.fda.gov/cosmetics/productsingredients/ingredients/ucm128042.htm on October 14, 2014.

US Food and Drug Administration. Federal Register, June 9, 2003. Antiperspirant Drug Products For Over-the-Counter Human Use; Final Monograph. Accessed at http://www.fda.gov/ohrms/dockets/98fr/03-14140.htm on September 5, 2013.

Leave a Comment

Your email address will not be published.